deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02899065

Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department (Influenza)

Evaluation of the Roche Cobas Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

Sponsor: Roche Pharma AG

Conditions Influenza, Human
Interventions Pharmacist-Led Education Procalcitonin
Updated 18 times since 2017 Last updated: Sep 28, 2023 Started: Mar 6, 2018 Primary completion: Apr 15, 2022 Completion: May 20, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Influenza, Human and is currently completed. Roche Pharma AG leads this study, which shows 18 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Oct 2017 · 4 months · monthly snapshot~Oct 2017 – ~Feb 2018 · 4 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Feb 2020 · 9 months · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Mar 2022 · 10 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Nov 2023 · 14 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Nov 2023 — Jul 2024 [monthly]

    Completed NA

  4. Sep 2022 — Nov 2023 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Mar 2022 — Sep 2022 [monthly]

    Recruiting NA

▶ Show 13 earlier versions

  1. May 2021 — Mar 2022 [monthly]

    Recruiting NA

  2. Jan 2021 — May 2021 [monthly]

    Recruiting NA

  3. May 2020 — Jan 2021 [monthly]

    Recruiting NA

  4. Feb 2020 — May 2020 [monthly]

    Recruiting NA

  5. May 2019 — Feb 2020 [monthly]

    Recruiting NA

  6. Feb 2019 — May 2019 [monthly]

    Recruiting NA

  7. Jun 2018 — Feb 2019 [monthly]

    Recruiting NA

  8. Mar 2018 — Jun 2018 [monthly]

    Recruiting NA

  9. Feb 2018 — Mar 2018 [monthly]

    Recruiting NA

  10. Oct 2017 — Feb 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  11. Jun 2017 — Oct 2017 [monthly]

    Not Yet Recruiting NA

  12. Feb 2017 — Jun 2017 [monthly]

    Not Yet Recruiting NA

  13. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roche Pharma AG
  • University of California, Davis
Data source: University of California, Davis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations